| 초록 |
Introduction and aims: Patients starting peritoneal dialysis (PD) with active cardiovascular disease (CVD) show higher protein and albumin levels in peritoneal effluent. PWV is known as a strong independent predictor of cardiovascular mortality. We hypothesize that peritoneal albumin excretion in PD patients, can predict cardiovascular disease in new PD patients.
Methods: We performed a prospective observational study of 35 patients from a single center receiving stable PD for more than 6 months. We studied peritoneal protein and albumin excretion in these new PD patients and repeated the studies every 6 month. These patients were screened for subclinical peripheral artery disese (PAD) using the ankle–brachial index (ABI) measurement. The brachial-ankle pulse wave velocity (baPWV) was measured by using an ABI-form device. ABI and PWV were measured at the time of starting PD and at 6, 12, and 24 months thereafter.
Results: The average duration of follow-up was 26.5±17.6 months. Of these patients, 4 patients have coronary artery disease (CAD) and none have PAD. Initial peritoneal albumin excretion measured at first month of PD, was higher in CAD patients compared to non-CAD patients (p=0.013). Moreover, the increment was maintained through follow-up period (mean albumin excretion was higher in CAD and non-CAD, p=0.037). But, protein excretion was not different between groups. At 12 month PWV, peritoneal albumin excretion was elevated in upper 3rd tertile PWV group compared to lower two tertile groups (p=0.042 and p=0.034). During the study period, mean albumin excretion was directly related with PWV measured at first year after starting dialysis (r=0.39, p=0.017). Moreover, mean albumin excretion was inversely correlated with ABI during the first year of dialysis (r=-0.67, p=0.003).
Conclusions: Increased peritoneal albumin excretion was an important predictive marker and risk factor for developing cardiovascular disease in PD patients. |